Sutro Biopharma Inc

NASDAQ:STRO   10:56:47 AM EDT
4.51
+0.07 (+1.58%)
Earnings Announcements

Sutro Biopharma Reports First Quarter 2022 Financial Results

Published: 05/09/2022 20:56 GMT
Sutro Biopharma Inc (STRO) - Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated Milestones.
Q1 Revenue $5.9 Million.
Qtrly Loss per Share $0.84.
Q1 Earnings per Share View $-0.76, Revenue View $10.5 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $15.44 Million
Adjusted EPS is expected to be -$0.67

Next Quarter Revenue Guidance is expected to be $9.58 Million
Next Quarter EPS Guidance is expected to be -$0.83

More details on our Analysts Page.